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choice. Other decision makers prefer to see patient derived utili-
ties and only the SGRQ-U would meet that requirement.
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OBJECTIVES: To establish a conceptual framework that can be
used to guide the development of a new measure of patient-
reported dyspnea, including its impact upon valued activities.
METHODS: We identiﬁed key concepts through individual inter-
views with COPD patients (n = 15), reconciliation with scientiﬁc
literature and expert input (n = 16), and “think aloud” inter-
views with COPD patients (n = 10). RESULTS: Thematic analy-
sis of patient input suggested ﬁve components of the dyspnea
experience: breathlessness, fatigue, activity modiﬁcation, activity
limitation, and emotional response. Two major inﬂuences on
dyspnea were described as individual exertion and exposure
to environmental factors. Patients acknowledged a sense of
dyspnea-related fear, and reported distress over its impact on
health and activity limitation. They emphasized coping via
behavioral strategies and medication and reported effects of
dyspnea on stopping or scaling back activities, taking more time
to do things, and using adaptive measures or equipment. No
existing model of dyspnea in COPD incorporated all of these
concepts elucidated by patients. We therefore used Wilson &
Cleary’s (1995) general model to develop a dyspnea-speciﬁc
framework, using expert input and available literature. In this
framework, the most proximal of endpoints (dyspnea symptoms)
can impair function, and be mediated by personal and environ-
mental factors. CONCLUSION: Patient input was systematically
used to develop a comprehensive conceptual framework for
measurement of dyspnea and related functional limitations.
STROKE—Clinical Outcomes Studies
PST1
SEASONALVARIATION OFTRANSIENT ISCHEMIC ATTACK
(TIA) IN HUNGARY
Kriszbacher I, Csoboth I, Boncz I, Bódis J
University of Pécs, Pécs, Hungary
OBJECTIVES: The aim of our current study was to ﬁnd out
whether a weekly or seasonal variation can be revealed in the
onset of a transient ischemic attack (TIA) in Hungary during a
four year study period, and whether the occurrence of a TIA is
inﬂuenced by age or sex. METHODS: The study was performed
on patients received treatment at neurological departments in
Hungary between 2002 and 2005, and diagnosed with TIA
(N = 4898). Data was taken from the nationwide database of the
National Health Insurance Fund Administration (OEP), in accor-
dance with the International Classiﬁcation of Diseases (ICD)
(ICD codes G4580, G4590). RESULTS: Based on our results, the
onset of cerebrovascular diseases, such as a transient ischemic
attack (TIA), shows a weekly and seasonal variation. With con-
sideration to seasonal variation, the peak period of TIA is during
the months of spring, with lowest number of events during the
summer. There was a signiﬁcant difference in the number of
events during seasons (p < 0.01). The weekly peak of TIA-
morbidity was during the ﬁrst day of the week, on Monday,
showing a gradually decreasing tendency until Sunday. Differ-
ences between sexes were only found in the weekly distribution
of number of events. The difference between age-groups proved
to be signiﬁcant only in weekly analysis and the decrease on
weekends is signiﬁcantly higher in patients aged over 65 years
(p < 0.01). CONCLUSION: In summary, the results of our study
reveals, that the occurrence of TIA shows a certain variation with
consideration to seasons and the days of the week.
STROKE—Cost Studies
PST2
A CRITICAL REVIEW OF PUBLISHED ECONOMIC
MODELLING STUDIES IN ISCHAEMIC STROKE
Saragoussi D, Guilhaume C, Sapin C, François C
H. Lundbeck A/S, Paris, France
OBJECTIVES: To review and synthesise the various methods
used for cost-effectiveness (CE) modelling evaluating acute
ischaemic stroke (AIS) treatment. METHODS: A literature
search was performed in December 2006 through PubMed using
the following search criteria: English language, publication date
between 1995 and 2006, “cost-effectiveness” and “stroke” as
key words. Only models were selected. They were reviewed
according to a predeﬁned reading grid. Structure, inputs and
results were studied. RESULTS: Twelve models were retrieved,
which evaluated thrombolytic agents or more general AIS man-
agement. The setting was either Europe, the US or Australia. The
perspective was always societal. The general structure was
similar between models (Markov model +/- decision tree) with a
long-term horizon. States were deﬁned by patients’ vital status
and disability level. However, some variability was found in the
deﬁnition of disability (different scales, different thresholds) and
in the choice of events to be included in the model (stroke
recurrence, hemorrhage, cardiovascular event). Some inputs were
comparable between models, namely probability of events and
utilities per state. However, disability/mortality probabilities
and costs per state were very different according to the country
and calendar year. Long-term probabilities were often assump-
tions. Cost-effectiveness was most often expressed as cost per
Quality-of-life Adjusted Life Years (QALY). One-way sensitivity
analyses (SA) allowed identifying costs and utilities for depen-
dent patients as drivers. Less often, probabilistic SA were per-
formed in order to assess the robustness of the ﬁndings.
CONCLUSION: The general structure of models evaluating CE
of acute phase treatment in AIS seems to be consensual.
However, there is a general lack of information on models’
drivers. Inﬂuence of local AIS evolution data (mortality/
disability) after acute phase and impact of disability on long-term
outcomes should be tested. Once drivers identiﬁed, related robust
epidemiological and economic data (notably long-term) should
be used as input.
STROKE—Patient Reported Outcomes
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STROKE SURVIVORS’ CHANGE IN HEALTH RELATED
QUALITY OF LIFE OVERTIME AS MEASURED BYTHE STROKE
IMPACT SCALE
Wasserman J, Godwin KM, Ostwald SK, Cron S
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OBJECTIVES: The goal of this study was to analyze changes in
disease-speciﬁc HRQoL over time. METHODS: The Stroke
Impact Scale (SIS) was administered to 33 ﬁrst-time stroke sur-
vivors discharged home from the hospital at baseline, 3, 6, 9 and
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